Biotechnology and Medical Research (TRBC)

Israeli firm gets U.S. nod for advanced trials for non-opiate…

Israeli firm gets U.S. nod for advanced trials for non-opiate…

Published 10/07/2018

JERUSALEM (Reuters) - Israeli pharmaceuticals company PainReform has received approval from the U.S. Food and Drug Administration (FDA) to begin late-stage clinical studies for a [more…]

CTI Biopharma’s cancer drug fails late-stage trial, shares tumble

CTI Biopharma’s cancer drug fails late-stage trial, shares tumble

Published 09/07/2018

(Reuters) - CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the main goal of a late-stage [more…]

Biogen, Eisai’s Alzheimer’s drug succeeds in mid-stage trial,…

Biogen, Eisai’s Alzheimer’s drug succeeds in mid-stage trial,…

Published 06/07/2018

(Reuters) - Japanese drugmaker Eisai Co and Biogen Inc said that the final analysis of a mid-stage trial of their Alzheimer’s drug showed positive results [more…]

U.S. approves first marijuana plant-derived drug for epilepsy

U.S. approves first marijuana plant-derived drug for epilepsy

Published 26/06/2018

(Reuters) - The U.S. health regulator approved GW Pharmaceuticals Plc’s epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the [more…]

Merrimack to scrap development of pancreatic cancer treatment

Merrimack to scrap development of pancreatic cancer treatment

Published 25/06/2018

(Reuters) - Merrimack Pharmaceuticals Inc said on Monday it would stop developing its experimental treatment for pancreatic cancer after it failed to meet the main [more…]

Mixed results for Bristol/Nektar combination in cancer trial

Mixed results for Bristol/Nektar combination in cancer trial

Published 04/06/2018

Chicago (Reuters) - Mixed results over the weekend from closely watched studies combining Bristol-Myers Squibb Co’s cancer immunotherapy with Nektar Therapeutics experimental drug NKTR-214, led [more…]

FDA wants to shorten new drug monopolies to cut costs

FDA wants to shorten new drug monopolies to cut costs

Published 03/06/2018

CHICAGO (Reuters) - In an effort to increase competition and bring down prescription drug prices, FDA Commissioner Dr. Scott Gottlieb wants to speed approval times [more…]

Many women with early-stage breast cancer can skip chemotherapy: study

Many women with early-stage breast cancer can skip chemotherapy: study

Published 03/06/2018

CHICAGO (Reuters) - Some 70 percent of women with early-stage breast cancer and an intermediate risk of cancer recurrence can safely skip chemotherapy after their [more…]

Merck’s Keytruda extends lung cancer survival in two trials

Merck’s Keytruda extends lung cancer survival in two trials

Published 03/06/2018

CHICAGO (Reuters) - Merck & Co’s immunotherapy Keytruda improved survival as a stand-alone treatment for newly-diagnosed lung cancer patients and with chemotherapy for hard-to-treat squamous [more…]

FDA chief outlines new ways to speed cancer drug approvals

FDA chief outlines new ways to speed cancer drug approvals

Published 02/06/2018

CHICAGO (Reuters) - The U.S. Food and Drug Administration is taking steps to streamline the approval process for cancer drugs, reviewing clinical trial data up [more…]